Back to feed
ELVNEnliven Therapeutics, Inc.
CIK 0001672619 · last filing 4d ago · 4 insider transactions
Buy volume
$0
0 buy transactions
Sell volume
$39.01M
4 sell transactions
Net flow
-$39.01M
Net selling
Total flow
$39.01M
4 priced transactions
Disclosure radarcross-source convergence
Divergent3/5 sources
32/100
Recent disclosures · timeline
- Form 44d ago
10% Owner · sold $39.01M
- Schedule 13D4d ago
9.5% stake · activist (13D)
Price · ELVN
Live chart by TradingViewLive chart via TradingView. Insider trade price and date are from the underlying SEC filing. Not financial advice.
ELVN insider flow· last 30 days
Buys Sellsnet -$39.01M
Institutional holders · 13F
Q1 2026 vs Q4 2025 · live SEC data4 funds hold$468.45M reported valueNet accumulating(3 adding · 2 reducing)
| Fund | Shares | Value | % of portfolio | QoQ |
|---|---|---|---|---|
| FMR LLC (Fidelity) | 6,829,246 | $267.71M | 0.0% | Trim-4% |
| BlackRock Inc | 3,684,707 | $144.44M | 0.0% | Add+2% |
| State Street Corp | 1,091,106 | $42.77M | 0.0% | Add |
5%+ stakes · Schedule 13D/G
| Filed | Filer | % class | Shares | Type | Purpose |
|---|---|---|---|---|---|
| 4d ago | ORBIMED ADVISORS LLC | 9.5% | 6,774,507 | 13D · active | [object Object] |
Recent insider transactions
| Filed | Insider | Transaction | Shares | Price | Value | Signal | Flags | |
|---|---|---|---|---|---|---|---|---|
4d ago Jun 22, 2026 | ORBIMED ADVISORS LLC 10% Owner | Sell · S | 787,024 | $45.38 | $35.72M | Mild sell-34 | ||
4d ago Jun 22, 2026 | ORBIMED ADVISORS LLC 10% Owner | Sell · S | 24,846 | $45.38 | $1.13M | Mild sell-34 | ||
4d ago Jun 22, 2026 | ORBIMED ADVISORS LLC 10% Owner | Sell · S | 46,776 | $45.00 | $2.10M | Mild sell-34 | ||
4d ago Jun 22, 2026 | ORBIMED ADVISORS LLC 10% Owner | Sell · S | 1,477 | $45.00 | $66.5K | Mild sell-34 |